Paper Details

  1. Home
  2. Paper Details

[Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].

Author: HirotaY, KatsunoM, KozuruM, KurataT, NihoY, NishimuraJ, OtsukaT, ShibuyaT, UikeN, YamanoY

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefmenoxime hemihydrochloride (CMX) was effective in treating various infections in patients with hematological diseases. It was well tolerated and had few side effects.
Paper Details　
Original Abstract of the Article :
Therapeutic effects on cefmenoxime hemihydrochloride (CMX, Bestcall), a new synthetic cephem antibiotic, were examined in the treatment of various infections complicated with hematological diseases. The number of patients treated with CMX was 37 including 5 cases of sepsis or suspected sepsis, 14 ca...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3488422

データ提供：米国国立医学図書館（NLM）

Cefmenoxime: A New Weapon in the Fight Against Infections

Infections can be particularly challenging to treat in patients with hematological diseases, who often have weakened immune systems. This study explores the therapeutic potential of cefmenoxime, a new synthetic cephem antibiotic, in treating infections in these vulnerable patients. The researchers conducted a clinical investigation to evaluate the effectiveness and safety of cefmenoxime in treating various infections complicated by hematological diseases.

The Desert of Hematological Infections: A Need for Effective Treatment

The study evaluated cefmenoxime in 37 patients with hematological diseases, including acute leukemia, chronic myelocytic leukemia, adult T cell leukemia, malignant lymphoma, Hodgkin's disease, and myeloma. The researchers found that cefmenoxime was effective in treating a wide range of infections in these patients, with good to excellent clinical results in 67.6% of cases.

Navigating the Oasis: A Safe and Effective Option

The study demonstrated that cefmenoxime was well tolerated, with minimal side effects and no abnormal laboratory findings attributable to the medication. The study provides evidence that cefmenoxime could be a safe and effective treatment option for infections in patients with hematological diseases.

Dr. Camel's Conclusion

This study sheds light on the effectiveness and safety of cefmenoxime in treating infections in patients with hematological diseases. The researchers found that cefmenoxime offered a safe and effective treatment option for a wide range of infections in this vulnerable patient population. This study provides valuable insights into the use of this antibiotic in this challenging clinical setting.
Date :
  1. Date Completed 1986-09-16
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3488422

DOI: Digital Object Identifier

3488422

Related Literature

Article Analysis
・Side Effects of cefotaxime injection
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.